Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 18, 2026
Why Is AST SpaceMobile (ASTS) Stock Down -6.51% Today?

Why Is AST SpaceMobile (ASTS) Stock Down -6.51% Today?

Key Takeaways

  • Shares fell 6.51%, or about $4.08, to roughly $58.63, down from a prior close of $62.71.
  • Primary catalyst: a wave of securities class-action lawsuits alleging the company overstated its capital position and the durability of its competitive lead.
  • Secondary drivers: renewed focus on competition from SpaceX's Starlink, funding and dilution concerns, and a history of analyst downgrades.
  • Broader context: the decline reversed much of a 5.8% rally in the prior session, underscoring volatile sentiment in the space-economy sector.
  • What to watch: the November 13 lead-plaintiff deadline, upcoming BlueBird satellite launches, and progress toward commercial service.

Opening Summary

AST SpaceMobile, Inc. (ASTS), the Texas-based company building the BlueBird satellite constellation to deliver broadband directly to unmodified smartphones, saw its stock slide sharply in Thursday's session. Shares of ASTS dropped 6.51%, or $4.08, to trade near $58.63, compared with a prior-session close of $62.71. The move, which reversed the prior day's gains, came as investors weighed newly announced securities litigation against the company and renewed doubts about its competitive and financial positioning.

Securities Class-Action Lawsuits Weigh on Sentiment

The dominant catalyst behind the selloff was a cluster of securities class-action filings and investor alerts. Multiple law firms announced that a class action has been filed on behalf of shareholders who purchased ASTS securities between March 4, 2025, and July 15, 2026, with a lead-plaintiff deadline of November 13, 2026.

The complaints allege that management made misleading statements about the sufficiency of the company's capital and liquidity position and about the durability of its competitive lead in the satellite direct-to-cellular market. They also point to what they describe as slow user adoption in the United States and Japan, and claim the company's capital needs and competitive pressures were moving in the opposite direction of its public disclosures. Legal overhangs of this kind can weigh heavily on high-valuation growth stocks, and ASTS was no exception.

Competitive and Funding Concerns Resurface

Beyond the litigation itself, the filings refocused investors on a familiar set of anxieties surrounding ASTS. The company is competing directly against SpaceX's Starlink, which has scaled its own direct-to-cell network rapidly and enjoys deep capital resources and launch capacity. Prior analyst downgrades have cited exactly these competitive dynamics, along with the contrast between the handful of BlueBird satellites launched to date and Starlink's far larger constellation.

Funding and dilution also remain in focus. The company has tapped the convertible-note market repeatedly to finance its satellite build-out, and investors have at times reacted negatively to the prospect of additional share dilution and capital intensity. While ASTS maintains a sizable cash balance and a growing contracted backlog, the path to positive free cash flow remains years away, leaving the stock sensitive to any headline that raises execution or capital risk.

Market Context and Trading Activity

The decline was notable for its speed and for how completely it erased the prior session's rally, when ASTS had climbed more than 5%. The reversal highlights the elevated volatility that has characterized the stock as it oscillates between operational milestones and legal or competitive setbacks. The move unfolded against a backdrop in which the broader space-economy complex has experienced sharp swings tied to launch schedules, spectrum developments, and the competitive threat posed by SpaceX's expanding ambitions.

From a technical standpoint, the slide pushed the stock back below recent levels it had briefly reclaimed, leaving traders focused on whether the shares can stabilize near current prices or face further pressure ahead of the litigation deadlines.

What Comes Next for ASTS

Looking ahead, investors will monitor several key signposts. The November 13 lead-plaintiff deadline will frame the near-term legal narrative, while the company's progress in launching additional BlueBird satellites toward its target of roughly 45 in orbit by early 2027 remains central to the investment thesis. Quarterly results and any updates on revenue guidance, gateway deployments, and government contracts will also matter, as will broader developments in the competitive landscape with Starlink.

Risks remain pronounced. Execution on satellite manufacturing and launch cadence, sustained capital needs, and the unresolved litigation all represent uncertainties that could keep volatility elevated in ASTS shares in the weeks ahead.

Trending AI Robots

For traders looking to navigate fast-moving stocks like ASTS, Tickeron's Trending AI Robots page offers a curated look at its strongest-performing AI trading bots. Tickeron hosts hundreds of AI-powered trading bots covering thousands of tickers, but only those demonstrating the strongest performance under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving users a way to explore automated approaches suited to different market environments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ASTS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ASTS in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 24, 2026

ASTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 33 cases where ASTS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 59 cases where ASTS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on ASTS as a result. In 67 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for ASTS just turned positive on September 17, 2026. Looking at past instances where ASTS's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.

Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASTS advanced for three days, in 235 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for ASTS entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. ASTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.381) is normal, around the industry mean (7.784). P/E Ratio (0.000) is within average values for comparable stocks, (69.686). ASTS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.067). ASTS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). ASTS's P/S Ratio (147.059) is very high in comparison to the industry average of (11.937).

Notable companies

The most notable companies in this group are Cisco Systems (NASDAQ:CSCO), Lumentum Holdings (NASDAQ:LITE), Hewlett Packard Enterprise Company (NYSE:HPE), Nokia Corp (NYSE:NOK), Ciena Corp (NYSE:CIEN), Ericsson (NASDAQ:ERIC).

Industry description

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

Market Cap

The average market capitalization across the Telecommunications Equipment Industry is 20.33B. The market cap for tickers in the group ranges from 1.59K to 424.77B. CSCO holds the highest valuation in this group at 424.77B. The lowest valued company is ABILF at 1.59K.

High and low price notable news

The average weekly price growth across all stocks in the Telecommunications Equipment Industry was 2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 11%. FEIM experienced the highest price growth at 35%, while NUR experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Telecommunications Equipment Industry was 54%. For the same stocks of the Industry, the average monthly volume growth was 5% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 57
Price Growth Rating: 58
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
ASTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a blank check company, which has formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization

Industry TelecommunicationsEquipment

Profile
Details
Industry
N/A
Address
2901 Enterprise Lane
Phone
+1 432 276-3966
Employees
1126
Web
https://www.ast-science.com
Interact to see
Advertisement
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.